1. Home
  2. CDXS vs BRY Comparison

CDXS vs BRY Comparison

Compare CDXS & BRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDXS
  • BRY
  • Stock Information
  • Founded
  • CDXS 2002
  • BRY 1909
  • Country
  • CDXS United States
  • BRY United States
  • Employees
  • CDXS N/A
  • BRY N/A
  • Industry
  • CDXS Major Chemicals
  • BRY Oil & Gas Production
  • Sector
  • CDXS Industrials
  • BRY Energy
  • Exchange
  • CDXS Nasdaq
  • BRY Nasdaq
  • Market Cap
  • CDXS 176.4M
  • BRY 186.1M
  • IPO Year
  • CDXS 2010
  • BRY N/A
  • Fundamental
  • Price
  • CDXS $2.47
  • BRY $2.90
  • Analyst Decision
  • CDXS Buy
  • BRY Hold
  • Analyst Count
  • CDXS 2
  • BRY 1
  • Target Price
  • CDXS $11.00
  • BRY $5.00
  • AVG Volume (30 Days)
  • CDXS 532.0K
  • BRY 928.9K
  • Earning Date
  • CDXS 05-14-2025
  • BRY 05-08-2025
  • Dividend Yield
  • CDXS N/A
  • BRY 12.32%
  • EPS Growth
  • CDXS N/A
  • BRY N/A
  • EPS
  • CDXS N/A
  • BRY N/A
  • Revenue
  • CDXS $59,345,000.00
  • BRY $830,412,000.00
  • Revenue This Year
  • CDXS $12.62
  • BRY N/A
  • Revenue Next Year
  • CDXS $22.11
  • BRY $2.60
  • P/E Ratio
  • CDXS N/A
  • BRY N/A
  • Revenue Growth
  • CDXS N/A
  • BRY N/A
  • 52 Week Low
  • CDXS $1.90
  • BRY $2.11
  • 52 Week High
  • CDXS $6.08
  • BRY $7.81
  • Technical
  • Relative Strength Index (RSI)
  • CDXS 53.65
  • BRY 58.11
  • Support Level
  • CDXS $2.23
  • BRY $2.36
  • Resistance Level
  • CDXS $2.59
  • BRY $2.63
  • Average True Range (ATR)
  • CDXS 0.13
  • BRY 0.14
  • MACD
  • CDXS 0.05
  • BRY 0.08
  • Stochastic Oscillator
  • CDXS 81.82
  • BRY 97.30

About CDXS Codexis Inc.

Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.

About BRY Berry Corporation (bry)

Berry Corp (bry) is a western United States independent upstream energy company with a focus on the conventional, long-lived oil reserves in the San Joaquin basin of California. Its operating segments includes Exploration and Production (E&P) and Well Servicing and Abandonment. The company generates maximum revenue from the Exploration and Production (E&P) segment.

Share on Social Networks: